Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12022338rdf:typepubmed:Citationlld:pubmed
pubmed-article:12022338lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:12022338lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12022338lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:12022338lifeskim:mentionsumls-concept:C0023413lld:lifeskim
pubmed-article:12022338lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:12022338lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12022338pubmed:issue5lld:pubmed
pubmed-article:12022338pubmed:dateCreated2002-5-22lld:pubmed
pubmed-article:12022338pubmed:languageenglld:pubmed
pubmed-article:12022338pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12022338pubmed:citationSubsetIMlld:pubmed
pubmed-article:12022338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12022338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12022338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12022338pubmed:statusMEDLINElld:pubmed
pubmed-article:12022338pubmed:monthMaylld:pubmed
pubmed-article:12022338pubmed:issn0315-162Xlld:pubmed
pubmed-article:12022338pubmed:authorpubmed-author:ErlichmanChar...lld:pubmed
pubmed-article:12022338pubmed:authorpubmed-author:MattesonEric...lld:pubmed
pubmed-article:12022338pubmed:authorpubmed-author:BunchThomas...lld:pubmed
pubmed-article:12022338pubmed:authorpubmed-author:LuthraHarvind...lld:pubmed
pubmed-article:12022338pubmed:issnTypePrintlld:pubmed
pubmed-article:12022338pubmed:volume29lld:pubmed
pubmed-article:12022338pubmed:ownerNLMlld:pubmed
pubmed-article:12022338pubmed:authorsCompleteYlld:pubmed
pubmed-article:12022338pubmed:pagination1109-10lld:pubmed
pubmed-article:12022338pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:meshHeadingpubmed-meshheading:12022338...lld:pubmed
pubmed-article:12022338pubmed:year2002lld:pubmed
pubmed-article:12022338pubmed:articleTitleAn open-label, phase I/II study of 5-fluorouracil plus leucovorin in the treatment of rheumatoid arthritis.lld:pubmed
pubmed-article:12022338pubmed:publicationTypeLetterlld:pubmed
pubmed-article:12022338pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12022338pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:12022338pubmed:publicationTypeClinical Trial, Phase Illd:pubmed